Hikma Pharmaceuticals (HIK)

 

HIK Share PerformanceMore

52 week high2,703.0 02/08/16
52 week low1,575.0 04/11/16
52 week change -374.0 (-17.83%)
4 week volume17,496,969 15/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today reaffirms its overweight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised...

Director Deals - Hikma Pharmaceuticals PLC (HIK)

Said Darwazah, Chairman, bought 150,000 shares in the company on the 6th December 2016 at a price of 1679.00p. The Dire...

Director Deals - Hikma Pharmaceuticals PLC (HIK)

Said Darwazah, Chairman, bought 150,000 shares in the company on the 6th December 2016 at a price of 1679.00p. The Dire...

Director Deals - Hikma Pharmaceuticals PLC (HIK)

Said Darwazah, Chairman, bought 150,000 shares in the company on the 6th December 2016 at a price of 1679.00p. The Dire...

Director/PDMR Shareholding

RNS Number: 1937R Hikma Pharmaceuticals Plc 07 December 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pha...

Total Voting Rights

RNS Number: 1352R Hikma Pharmaceuticals Plc 06 December 2016 Hikma Pharmaceuticals PLC Voting Rights and Capital LONDON, 6 December 2016, Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) notifies the market that its capital consists of 239,954,532 ordinary shares with voting rights. There are nil shares held in treasury. The above figure may...

Director/PDMR Shareholding

RNS Number: 9861Q Hikma Pharmaceuticals Plc 05 December 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by HMS Holdings SAL of Ordinary Shares of 10 pence each in Hikma P...

Director/PDMR Shareholding

RNS Number: 8836Q Hikma Pharmaceuticals Plc 02 December 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pha...

Latest discussion posts More

  • Re: Barclays overweight 3400p PT

    Fred - much appreciate the time to reply and explain the way spread betters operate in more detail. Enjoy your holiday (Diageo's shares could do with a boost!) and ...
    9-Dec-2016
    Hardboy
  • Re: Barclays overweight 3400p PT

    Well done Fred, and thanks for all your input over recent months. Enjoy the holidays and we all look forward to some upside in the new year.
    9-Dec-2016
    Openwoe
  • Barclays overweight 3400p PT

    Barclays Capital today reaffirms its overweight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 3400p (from 2900p). Good morning ...
    9-Dec-2016
    Fred Prior

Users' HoldingsMore

Users who hold Hikma Pharmaceuticals also hold..
LLOYDS GRP.29%
GLAXOSMITHKLINE28%
RDS 'B'27%
VODAFONE GRP.23%
BP23%

Codes & Symbols

ISINGB00B0LCW083
SymbolsHIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK